Treatment of oral florid papillomatosis with systemic administration of photocarcinorin: an effective photodynamic therapy

Photomed Laser Surg. 2010 Dec;28(6):831-3. doi: 10.1089/pho.2009.2662. Epub 2010 Aug 1.

Abstract

Objectives: To evaluate the safety and effect of systemic administration of photosensitizer Photocarcinorin (PsD-007) in the treatment of oral florid papillomatosis (OFP).

Background: OFP is a rare and refractory disease characterized by multiple papillomatous lesions. The outcomes of many methods for OFP are not satisfactory.

Materials and methods: Photosensitizer Photocarcinorin (5 mg/kg) was intravenously injected into a 59-year-old woman with widespread OFP, and the lesions were irradiated for 10 min by using a 635-nm laser beam of 177 mW/cm(2) intensity and 106.2 J/cm(2) energy density. The therapy was performed once a month for 3 months in total.

Results: After three courses, the small lesions disappeared, and the larger ones were reduced by ≥80%. The adverse effects were minimal.

Conclusions: Systemic PDT is an effective and successful treatment modality for OFP, especially in elderly patients.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Hematoporphyrins / therapeutic use*
  • Humans
  • Middle Aged
  • Mouth Neoplasms / drug therapy*
  • Papilloma / drug therapy*
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use*

Substances

  • Hematoporphyrins
  • Photosensitizing Agents
  • photocarcinorin